Hyperthermia / tumCV Cancer Research Results

HPT, Hyperthermia: Click to Expand ⟱
Features:
Mild Hyperthermia (Approximately 39°C to 41°C
Pathways and Effects:
-Heat Shock Protein (HSP) Induction: Mild heat stress triggers the production of HSPs (e.g., HSP70, HSP90) that help cells cope with stress, which can sometimes provide a transient protective effect. However, these proteins can also act as immunomodulators.
-Modulation of the Immune System: Mild hyperthermia can enhance dendritic cell activation and improve antigen presentation, leading to the stimulation of anti-tumor immune responses.
-Vasodilation: Increased blood flow and improved oxygenation can sensitize tumors to radiation therapy and certain chemotherapeutics.

Moderate Hyperthermia (Approximately 41°C to 43°C)
Pathways and Effects:
-Enhanced Cytotoxicity: At temperatures in this range, tumor cells become more vulnerable to radiation and some chemotherapeutic agents. This is partly due to the inhibition of DNA repair pathways.
-Increased Permeability: Moderate heat can increase the permeability of cellular membranes, aiding in drug delivery and the uptake of chemotherapeutic agents.
-Induction of Apoptosis: Elevated temperatures can trigger apoptotic signaling pathways in cancer cells, sometimes in conjunction with other therapies.

High Hyperthermia / Thermal Ablation (Approximately 43°C to 50°C and above)
Pathways and Effects:
-Direct Cytotoxicity: High temperatures can lead to protein denaturation, membrane disruption, and direct cell death.
-Coagulative Necrosis: Sustained high temperatures cause irreversible cell injury leading to necrosis of tumor tissues.
-Vascular Damage: Hyperthermia in this range can damage tumor vasculature, reducing blood supply and indirectly causing tumor cell death.
-Enhanced Immune Response: Although high temperatures can cause immediate cell death, the release of tumor antigens and damage-associated molecular patterns (DAMPs) can stimulate an anti-tumor immune response


Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Proteotoxic stress / protein denaturation Misfolded protein burden ↑; proteostasis overload ↑ Heat stress response (tolerance higher if well-perfused) P, R Core physical stressor Direct heat disrupts protein folding and complex stability; tumors can be more vulnerable due to baseline stress and poor perfusion.
2 Heat Shock Response (HSF1 → HSPs) HSP70/HSP90 ↑; stress tolerance ↑ (can be protective) HSP induction ↑ (protective) R, G Adaptive survival program HSP induction is a major adaptation; can blunt repeated heat exposures and is a key reason scheduling matters.
3 DNA damage repair inhibition / radiosensitization HR repair ↓; DNA repair capacity ↓ (reported) ↔ (tissue-dependent) R Sensitization to radiation Hyperthermia can impair DNA repair processes (notably homologous recombination), increasing radiation effectiveness when timed appropriately.
4 Tumor perfusion / oxygenation changes Perfusion ↑ (often) → oxygenation ↑; hypoxia ↓ (context) Perfusion ↑ P, R Microenvironment modulation Improved perfusion can increase oxygenation (helping radiotherapy) and improve delivery of some drugs; effects depend on local vascular state.
5 Cell membrane / cytoskeleton disruption Membrane permeability ↑; cytoskeletal stress ↑ ↔ / injury possible at higher exposures P, R Physical cell stress Heat can increase permeability and alter membrane trafficking; contributes to drug uptake in some settings.
6 Intrinsic apoptosis / necrosis (dose-dependent) Apoptosis ↑ or necrosis ↑ at higher thermal dose Collateral injury risk if overdosed R, G Direct cytotoxicity (thermal dose dependent) At moderate hyperthermia, sensitization dominates; at higher thermal dose, direct cell killing becomes more prominent.
7 Immune activation / DAMP release (ICD-like signals) DAMPs ↑; antigen presentation ↑ (reported) — G Immune support Heat stress and tumor cell damage can release DAMPs and promote immune visibility; strength varies by regimen and tumor type.
8 Vascular effects (edema, vessel damage) at higher dose Vascular injury ↑ at higher thermal dose Normal tissue injury risk ↑ R, G Toxicity / local control effects At higher temperatures or prolonged exposure, vascular damage contributes to tumor control but increases normal tissue risk.
9 Chemo-sensitization (drug delivery + stress synergy) Drug uptake ↑; cytotoxic synergy ↑ (reported) Systemic toxicity may ↑ depending on regimen R, G Combination leverage Heat can potentiate some agents (e.g., platinum drugs) and improve delivery; regimen-specific.
10 Thermal dose / parameter dependence (time×temp) Outcome depends on temperature, duration, targeting, and timing vs RT/chemo Safety depends on precision and monitoring — Translation constraint Hyperthermia is highly dose-dependent; “too little” yields little sensitization, “too much” increases burns/necrosis risk.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (direct heat stress; perfusion/permeability shifts begin)
  • R: 30 min–3 hr (HSP induction; DNA repair suppression; apoptosis initiation)
  • G: >3 hr (phenotype outcomes: immune effects, sensitization results, tissue injury)
tumCV, Cell Viability: Click to Expand ⟱
Source:
Type:
Cell Viability
Scientific Papers found: Click to Expand⟱
5049- HPT,    Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer
- vitro+vivo, PC, Panc02 - vitro+vivo, PC, Bxpc-3
tumCV↓, proCasp↑, ROS↑, Ki-67↓, TOP2↓, TumVol↓,
5051- HPT,  doxoR,    Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells
- in-vitro, Melanoma, A375
tumCV↓, TumCCA↑, ROS↑, eff↑,
1674- PBG,  SDT,  HPT,    Study on the effect of a triple cancer treatment of propolis, thermal cycling-hyperthermia, and low-intensity ultrasound on PANC-1 cells
- in-vitro, PC, PANC1 - in-vitro, Nor, H6c7
tumCV↓, ROS↑, eff↑, Dose∅, selectivity↑, MMP↓, mtDam↑, cl‑PARP↑, p‑ERK↓, p‑JNK↑, p‑p38↑, eff↓, ChemoSen↑,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

ROS↑, 3,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 1,   mtDam↑, 1,  

Cell Death ⓘ

proCasp↑, 1,   p‑JNK↑, 1,   p‑p38↑, 1,  

Transcription & Epigenetics ⓘ

tumCV↓, 3,  

DNA Damage & Repair ⓘ

cl‑PARP↑, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

p‑ERK↓, 1,   TOP2↓, 1,  

Migration ⓘ

Ki-67↓, 1,  

Drug Metabolism & Resistance ⓘ

ChemoSen↑, 1,   Dose∅, 1,   eff↓, 1,   eff↑, 2,   selectivity↑, 1,  

Clinical Biomarkers ⓘ

Ki-67↓, 1,  

Functional Outcomes ⓘ

TumVol↓, 1,  
Total Targets: 19

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: tumCV, Cell Viability
3 Hyperthermia
1 doxorubicin
1 Propolis -bee glue
1 SonoDynamic Therapy UltraSound
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:98  Target#:897  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page